Alaunos Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Alaunos Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2018 to Q1 2024.
  • Alaunos Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $2K, a 99.7% decline year-over-year.
  • Alaunos Therapeutics, Inc. annual Depreciation for 2023 was $2.32M, a 16.1% decline from 2022.
  • Alaunos Therapeutics, Inc. annual Depreciation for 2022 was $2.76M, a 6.24% increase from 2021.
  • Alaunos Therapeutics, Inc. annual Depreciation for 2021 was $2.6M, a 130% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2K -$694K -99.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $696K +$7K +1.02% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $689K +$149K +27.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $540K +$398K +280% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q1 2020 $142K +$2K +1.43% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $140K +$23K +19.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $117K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.